These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 36998036)

  • 21. Mast cell marker gene signature in head and neck squamous cell carcinoma.
    Cai Z; Tang B; Chen L; Lei W
    BMC Cancer; 2022 May; 22(1):577. PubMed ID: 35610596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A model of seven immune checkpoint-related genes predicting overall survival for head and neck squamous cell carcinoma.
    Song D; Tian J; Han X; Li X
    Eur Arch Otorhinolaryngol; 2021 Sep; 278(9):3467-3477. PubMed ID: 33449165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating Tumour Cell Expression of Immune Markers as Prognostic and Therapeutic Biomarkers in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.
    Payne K; Pugh M; Brooks J; Batis N; Taylor G; Nankivell P; Mehanna H
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33153130
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Construction of a hypoxia-derived gene model to predict the prognosis and therapeutic response of head and neck squamous cell carcinoma.
    Wang H; Zheng L
    Sci Rep; 2022 Aug; 12(1):13538. PubMed ID: 35945448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prognostic value of TMB and the relationship between TMB and immune infiltration in head and neck squamous cell carcinoma: A gene expression-based study.
    Zhang L; Li B; Peng Y; Wu F; Li Q; Lin Z; Xie S; Xiao L; Lin X; Ou Z; Cai T; Rong H; Fan S; Li J
    Oral Oncol; 2020 Nov; 110():104943. PubMed ID: 32919362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dickkopf-1 is an immune infiltration-related prognostic biomarker of head and neck squamous cell carcinoma.
    Zhao C; Liu L; He Q; Li Y; Feng J; Chen Y; Li Y; Xu X; Zhu S; Ye Y; Wen Y; Zeng Z; Zhou D; Jin F
    Aging (Albany NY); 2024 Feb; 16(4):3837-3855. PubMed ID: 38376441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and verification of eight cancer-associated fibroblasts related genes as a prognostic signature for head and neck squamous cell carcinoma.
    Dong L; Sun Q; Song F; Song X; Lu C; Li Y; Song X
    Heliyon; 2023 Mar; 9(3):e14003. PubMed ID: 36938461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic role of DFNA5 in head and neck squamous cell carcinoma revealed by systematic expression analysis.
    Liu Z; Liu H; Dong Q; Li H; Zhang B; Liu Y; Zhong L; Tang H
    BMC Cancer; 2021 Aug; 21(1):951. PubMed ID: 34433433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High eukaryotic initiation factor 5A2 expression predicts poor prognosis and may participate in the SNHG16/miR-10b-5p/EIF5A2 regulatory axis in head and neck squamous cell carcinoma.
    Ye S; Wang D; Jin M; Du J; Chen X; Zhang H; Zhou C; Fang S; Liu K
    J Clin Lab Anal; 2023 Jan; 37(1):e24820. PubMed ID: 36550070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune Infiltration-Related ceRNA Network Revealing Potential Biomarkers for Prognosis of Head and Neck Squamous Cell Carcinoma.
    Zhao S; Peng M; Wang Z; Cao J; Zhang X; Yu R; Huang T; Lian W
    Dis Markers; 2022; 2022():1014347. PubMed ID: 36097539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and analysis of genes associated with head and neck squamous cell carcinoma by integrated bioinformatics methods.
    Jin Y; Yang Y
    Mol Genet Genomic Med; 2019 Aug; 7(8):e857. PubMed ID: 31304688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma.
    Zhu W; Ye Z; Chen L; Liang H; Cai Q
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lactate dehydrogenase B as a metabolism-related marker for immunotherapy in head and neck squamous cell carcinoma.
    Xu X; Pan X; Fan Z; Xia J; Ren X
    Cell Signal; 2024 Aug; 120():111200. PubMed ID: 38719019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. UBE2C promotes the progression of head and neck squamous cell carcinoma.
    Jin Z; Zhao X; Cui L; Xu X; Zhao Y; Younai F; Messadi D; Hu S
    Biochem Biophys Res Commun; 2020 Mar; 523(2):389-397. PubMed ID: 31870550
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An ion-channel-gene-based prediction model for head and neck squamous cell carcinoma: Prognostic assessment and treatment guidance.
    Han Y; Shi Y; Chen B; Wang J; Liu Y; Sheng S; Fu Z; Shen C; Wang X; Yin S; Li H
    Front Immunol; 2022; 13():961695. PubMed ID: 36389709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioinformatics analyses proposed xenotropic and polytropic retrovirus receptor 1 as a potential diagnostic and prognostic biomarker and immunotherapeutic target in head and neck squamous cell carcinoma.
    Wang L
    Auris Nasus Larynx; 2023 Feb; 50(1):134-150. PubMed ID: 35690506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of immune-related genes and immune cell infiltration analysis in the tumor microenvironment of head and neck squamous cell carcinoma.
    Wang Z; Yuan H; Huang J; Hu D; Qin X; Sun C; Chen G; Wang B
    Head Neck; 2021 Jan; 43(1):182-197. PubMed ID: 33009692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification and validation of a prognostic signature of autophagy, apoptosis and pyroptosis-related genes for head and neck squamous cell carcinoma: to imply therapeutic choices of HPV negative patients.
    Nan Z; Dou Y; Chen A; Wang K; Sun J; Meng Z; Neckenig M; Ai D; Liu S; Dong Z; Ma C; Cheng Y; Qu X
    Front Immunol; 2022; 13():1100417. PubMed ID: 36703967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. E2F4 transcription factor is a prognostic biomarker related to immune infiltration of head and neck squamous cell carcinoma.
    Qi L; Ren Z; Li W
    Sci Rep; 2022 Jul; 12(1):12132. PubMed ID: 35840663
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of factors related to immunotherapy efficacy and prognosis in patients with advanced head and neck squamous cell carcinoma.
    Xu X; Li R; Zhang L; Zhu G; Ren D; Wu L; Gong X
    Diagn Pathol; 2021 Nov; 16(1):110. PubMed ID: 34823553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.